Yingzhuo Xu
Union Hospital(CN)Wuhan Union Hospital(CN)Huazhong University of Science and Technology(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, RNA modifications and cancer, DNA Repair Mechanisms, Immune cells in cancer, Lung Cancer Research Studies
Most-Cited Works
- → CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer(2020)86 cited
- → Targeting KDM4C enhances CD8+ T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer(2022)81 cited
- → BRD4‐IRF1 axis regulates chemoradiotherapy‐induced PD‐L1 expression and immune evasion in non‐small cell lung cancer(2022)62 cited
- → NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer(2022)60 cited
- → Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury(2023)42 cited
- → REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axis(2022)29 cited
- → Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer(2022)29 cited
- → Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors(2022)23 cited
- → Targeting polymerase θ impairs tumorigenesis and enhances radiosensitivity in lung adenocarcinoma(2023)18 cited
- → Effect of Stereotactic Body Radiation Therapy on Diverse Organ Lesions in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors(2023)